Tom O'Bryan, DC - Fire in the Hole: Intestinal Permeability (2017 Conference) (LDN, low dose naltrexone)
Three things in the development of autoimmune diseases: the gene for that particular disease, the environmental trigger that that sets it off, and loss of intestinal barrier function. The autoimmune process can be arrested if the interplay between genes and the environment is prevented by reestablishing intestinal barrier function. Biomarkers help identify autoimmune diseases. Clinicians need more training on diagnosing and treating autoimmune diseases.